Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands

Hyun Ju Cho, Sujata Acharjee, Mi Jin Moon, Da Young Oh, Hubert Vaudry, Hyuk Bang Kwon, Jae Young Seong

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recently, we cloned many of the bullfrog neuropeptide G protein-coupled receptors (GPCRs), including receptors for vasotocin (VT), mesotocin, gonadotropin-releasing hormone (GnRH), neurotensin, apelin, and metastin. Bullfrog GPCRs usually have high affinity for bullfrog ligands but relatively low affinity for mammalian ligands. Reciprocally, synthetic agonists and antagonists developed based upon mammalian ligands display lower affinity at bullfrog receptors. Studies using chimeric or domain-swapped receptors indicate that the motifs responsible for differential ligand selectivity usually reside within transmembrane domain 6 (TMD6)-extracellular loop 3 (ECL3)-transmembrane domain 7 (TMD7). Triple mutation of mammalian V1aR (Phe 6.51 to Tyr, Ile 6.53 to Thr, and Pro 7.33 to Thr) increases VT affinity but greatly reduces arginine vasopressin affinity. This binding profile is similar to that of bullfrog VT1R. Changing just three amino acids in the bullfrog GnRH receptor-1 (i.e. Ser-Gln-Ser in the ECL3) to those found in the type-I mammalian GnRH receptor (i.e. Ser-Glu-Pro) reverses GnRH selectivity. In conclusion, specific receptor motifs that govern ligand selectivity can be determined by comparative molecular analyses of GPCRs and their ligands. Such analysis provides clues for understanding how GPCRs maintain high affinity to their authentic ligands.

Original languageEnglish
Pages (from-to)98-107
Number of pages10
JournalGeneral and Comparative Endocrinology
Volume153
Issue number1-3
DOIs
Publication statusPublished - 2007 Aug 1

Fingerprint

Neuropeptide Receptors
Molecular Evolution
Rana catesbeiana
Ligands
G-Protein-Coupled Receptors
LHRH Receptors
Kisspeptins
Vasotocin
Neurotensin
Arginine Vasopressin
Neuropeptides
Gonadotropin-Releasing Hormone
Amino Acids
Mutation

Keywords

  • Coevolution
  • G protein-coupled receptors
  • Ligand selectivity
  • Neuropeptides

ASJC Scopus subject areas

  • Endocrinology

Cite this

Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. / Cho, Hyun Ju; Acharjee, Sujata; Moon, Mi Jin; Oh, Da Young; Vaudry, Hubert; Kwon, Hyuk Bang; Seong, Jae Young.

In: General and Comparative Endocrinology, Vol. 153, No. 1-3, 01.08.2007, p. 98-107.

Research output: Contribution to journalArticle

Cho, Hyun Ju ; Acharjee, Sujata ; Moon, Mi Jin ; Oh, Da Young ; Vaudry, Hubert ; Kwon, Hyuk Bang ; Seong, Jae Young. / Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. In: General and Comparative Endocrinology. 2007 ; Vol. 153, No. 1-3. pp. 98-107.
@article{dd4c81810ec9460a8d9867f27d649fd4,
title = "Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands",
abstract = "Recently, we cloned many of the bullfrog neuropeptide G protein-coupled receptors (GPCRs), including receptors for vasotocin (VT), mesotocin, gonadotropin-releasing hormone (GnRH), neurotensin, apelin, and metastin. Bullfrog GPCRs usually have high affinity for bullfrog ligands but relatively low affinity for mammalian ligands. Reciprocally, synthetic agonists and antagonists developed based upon mammalian ligands display lower affinity at bullfrog receptors. Studies using chimeric or domain-swapped receptors indicate that the motifs responsible for differential ligand selectivity usually reside within transmembrane domain 6 (TMD6)-extracellular loop 3 (ECL3)-transmembrane domain 7 (TMD7). Triple mutation of mammalian V1aR (Phe 6.51 to Tyr, Ile 6.53 to Thr, and Pro 7.33 to Thr) increases VT affinity but greatly reduces arginine vasopressin affinity. This binding profile is similar to that of bullfrog VT1R. Changing just three amino acids in the bullfrog GnRH receptor-1 (i.e. Ser-Gln-Ser in the ECL3) to those found in the type-I mammalian GnRH receptor (i.e. Ser-Glu-Pro) reverses GnRH selectivity. In conclusion, specific receptor motifs that govern ligand selectivity can be determined by comparative molecular analyses of GPCRs and their ligands. Such analysis provides clues for understanding how GPCRs maintain high affinity to their authentic ligands.",
keywords = "Coevolution, G protein-coupled receptors, Ligand selectivity, Neuropeptides",
author = "Cho, {Hyun Ju} and Sujata Acharjee and Moon, {Mi Jin} and Oh, {Da Young} and Hubert Vaudry and Kwon, {Hyuk Bang} and Seong, {Jae Young}",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.ygcen.2006.12.013",
language = "English",
volume = "153",
pages = "98--107",
journal = "General and Comparative Endocrinology",
issn = "0016-6480",
publisher = "Academic Press Inc.",
number = "1-3",

}

TY - JOUR

T1 - Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands

AU - Cho, Hyun Ju

AU - Acharjee, Sujata

AU - Moon, Mi Jin

AU - Oh, Da Young

AU - Vaudry, Hubert

AU - Kwon, Hyuk Bang

AU - Seong, Jae Young

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Recently, we cloned many of the bullfrog neuropeptide G protein-coupled receptors (GPCRs), including receptors for vasotocin (VT), mesotocin, gonadotropin-releasing hormone (GnRH), neurotensin, apelin, and metastin. Bullfrog GPCRs usually have high affinity for bullfrog ligands but relatively low affinity for mammalian ligands. Reciprocally, synthetic agonists and antagonists developed based upon mammalian ligands display lower affinity at bullfrog receptors. Studies using chimeric or domain-swapped receptors indicate that the motifs responsible for differential ligand selectivity usually reside within transmembrane domain 6 (TMD6)-extracellular loop 3 (ECL3)-transmembrane domain 7 (TMD7). Triple mutation of mammalian V1aR (Phe 6.51 to Tyr, Ile 6.53 to Thr, and Pro 7.33 to Thr) increases VT affinity but greatly reduces arginine vasopressin affinity. This binding profile is similar to that of bullfrog VT1R. Changing just three amino acids in the bullfrog GnRH receptor-1 (i.e. Ser-Gln-Ser in the ECL3) to those found in the type-I mammalian GnRH receptor (i.e. Ser-Glu-Pro) reverses GnRH selectivity. In conclusion, specific receptor motifs that govern ligand selectivity can be determined by comparative molecular analyses of GPCRs and their ligands. Such analysis provides clues for understanding how GPCRs maintain high affinity to their authentic ligands.

AB - Recently, we cloned many of the bullfrog neuropeptide G protein-coupled receptors (GPCRs), including receptors for vasotocin (VT), mesotocin, gonadotropin-releasing hormone (GnRH), neurotensin, apelin, and metastin. Bullfrog GPCRs usually have high affinity for bullfrog ligands but relatively low affinity for mammalian ligands. Reciprocally, synthetic agonists and antagonists developed based upon mammalian ligands display lower affinity at bullfrog receptors. Studies using chimeric or domain-swapped receptors indicate that the motifs responsible for differential ligand selectivity usually reside within transmembrane domain 6 (TMD6)-extracellular loop 3 (ECL3)-transmembrane domain 7 (TMD7). Triple mutation of mammalian V1aR (Phe 6.51 to Tyr, Ile 6.53 to Thr, and Pro 7.33 to Thr) increases VT affinity but greatly reduces arginine vasopressin affinity. This binding profile is similar to that of bullfrog VT1R. Changing just three amino acids in the bullfrog GnRH receptor-1 (i.e. Ser-Gln-Ser in the ECL3) to those found in the type-I mammalian GnRH receptor (i.e. Ser-Glu-Pro) reverses GnRH selectivity. In conclusion, specific receptor motifs that govern ligand selectivity can be determined by comparative molecular analyses of GPCRs and their ligands. Such analysis provides clues for understanding how GPCRs maintain high affinity to their authentic ligands.

KW - Coevolution

KW - G protein-coupled receptors

KW - Ligand selectivity

KW - Neuropeptides

UR - http://www.scopus.com/inward/record.url?scp=34547095506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547095506&partnerID=8YFLogxK

U2 - 10.1016/j.ygcen.2006.12.013

DO - 10.1016/j.ygcen.2006.12.013

M3 - Article

C2 - 17286976

AN - SCOPUS:34547095506

VL - 153

SP - 98

EP - 107

JO - General and Comparative Endocrinology

JF - General and Comparative Endocrinology

SN - 0016-6480

IS - 1-3

ER -